Trials / Completed
CompletedNCT00863577
Pharmacokinetic Study of Two Oral Bemiparin Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- Rovi Pharmaceuticals Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The primary pharmacokinetic analysis will be the correlation of the AUC amidolytic anti-Xa activity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral bemiparin | Bemiparin tablets and bemiparin tablets into hard gelatine capsules |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-12-01
- Completion
- 2011-01-01
- First posted
- 2009-03-18
- Last updated
- 2011-03-18
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT00863577. Inclusion in this directory is not an endorsement.